Erika Carmel-Tech Ltd (ERKA) - Net Assets

Latest as of December 2025: ILA9.79 Million ILA ≈ $26.24K USD

Based on the latest financial reports, Erika Carmel-Tech Ltd (ERKA) has net assets worth ILA9.79 Million ILA (≈ $26.24K USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA29.16 Million ≈ $78.17K USD) and total liabilities (ILA19.37 Million ≈ $51.93K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ERKA intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets ILA9.79 Million
% of Total Assets 33.57%
Annual Growth Rate 21.07%
5-Year Change -88.89%
10-Year Change N/A
Growth Volatility 337.73

Erika Carmel-Tech Ltd - Net Assets Trend (2019–2025)

This chart illustrates how Erika Carmel-Tech Ltd's net assets have evolved over time, based on quarterly financial data. See ERKA cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for Erika Carmel-Tech Ltd (2019–2025)

The table below shows the annual net assets of Erika Carmel-Tech Ltd from 2019 to 2025. For live valuation and market cap data, see ERKA company net worth.

Year Net Assets Change
2025-12-31 ILA9.79 Million
≈ $26.24K
-34.91%
2024-12-31 ILA15.04 Million
≈ $40.31K
-36.62%
2023-12-31 ILA23.73 Million
≈ $63.61K
-44.39%
2022-12-31 ILA42.67 Million
≈ $114.39K
-51.55%
2021-12-31 ILA88.06 Million
≈ $236.09K
+881.74%
2020-12-31 ILA8.97 Million
≈ $24.05K
+188.70%
2019-12-31 ILA3.11 Million
≈ $8.33K
--

Equity Component Analysis

This analysis shows how different components contribute to Erika Carmel-Tech Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 8433100000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components ILA94.19 Million 962.27%
Total Equity ILA9.79 Million 100.00%

Erika Carmel-Tech Ltd Competitors by Market Cap

The table below lists competitors of Erika Carmel-Tech Ltd ranked by their market capitalization.

Company Market Cap
Eko Export SA
WAR:EEX
$5.90 Million
Global Engine Group Holding Limited Ordinary Shares
NASDAQ:GLE
$5.90 Million
BioNexus Gene Lab Corp Common stock
NASDAQ:BGLC
$5.91 Million
BTU Metals Corp
V:BTU
$5.91 Million
Bhakti Agung Propertindo
JK:BAPI
$5.90 Million
Technoplus Ventures Ltd
TA:TNPV
$5.89 Million
Alchemy Resources Ltd
AU:ALY
$5.88 Million
Thai-German Products Public Company Limited
BK:TGPRO
$5.88 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Erika Carmel-Tech Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 15,037,000 to 9,788,000, a change of -5,249,000 (-34.9%).
  • Net loss of 5,853,000 reduced equity.
  • Other comprehensive income decreased equity by 4,784,999.
  • Other factors increased equity by 5,388,999.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income ILA-5.85 Million -59.8%
Other Comprehensive Income ILA-4.78 Million -48.89%
Other Changes ILA5.39 Million +55.06%
Total Change ILA- -34.91%

Book Value vs Market Value Analysis

This analysis compares Erika Carmel-Tech Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 224.76x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 879.78x to 224.76x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2019-12-31 ILA0.06 ILA52.80 x
2020-12-31 ILA0.17 ILA52.80 x
2021-12-31 ILA1.73 ILA52.80 x
2022-12-31 ILA0.82 ILA52.80 x
2023-12-31 ILA0.46 ILA52.80 x
2024-12-31 ILA0.29 ILA52.80 x
2025-12-31 ILA0.23 ILA52.80 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Erika Carmel-Tech Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -59.80%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -15.67%
  • • Asset Turnover: 1.28x
  • • Equity Multiplier: 2.98x
  • Recent ROE (-59.80%) is below the historical average (-12.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2019 75.41% 4.61% 1.95x 8.39x ILA2.03 Million
2020 138.94% 14.53% 1.80x 5.32x ILA11.57 Million
2021 -24.76% -22.52% 0.77x 1.42x ILA-30.61 Million
2022 -76.32% -64.71% 0.74x 1.60x ILA-36.83 Million
2023 -81.01% -64.32% 0.64x 1.98x ILA-21.59 Million
2024 -62.98% -24.95% 1.09x 2.31x ILA-10.97 Million
2025 -59.80% -15.67% 1.28x 2.98x ILA-6.83 Million

Industry Comparison

This section compares Erika Carmel-Tech Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $44,112,333
  • Average return on equity (ROE) among peers: -96.54%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Erika Carmel-Tech Ltd (ERKA) ILA9.79 Million 75.41% 1.98x $5.90 Million
Allmed Solutions Ltd (ALMD) $32.83 Million -61.45% 0.31x $8.63 Million
Erika Carmel Ltd (BCUR) $3.11 Million 75.41% 7.39x $4.69 Million
Bio-View Ltd (BIOV) $15.65 Million -6.88% 0.78x $20.36 Million
Brainsway Ltd (BWAY) $10.29 Million -23.30% 0.94x $440.88 Million
Erech Finance Cahalacha Ltd (EFNC) $4.33 Million -583.73% 4.42x $1.88 Million
Epitomee Medical Ltd (EPIT) $34.80 Million -16.33% 0.16x $53.52 Million
Human Xtensions Ltd (HUMX) $26.11 Million -140.33% 0.34x $2.12 Million
Ilex Medical (ILX) $266.15 Million 14.05% 0.82x $139.57 Million
Pulsenmore Ltd (PULS) $3.75 Million -126.31% 0.60x $22.89 Million

About Erika Carmel-Tech Ltd

TA:ERKA Israel Medical Devices
Market Cap
$5.90 Million
ILA2.20 Billion ILA
Market Cap Rank
#28243 Global
#408 in Israel
Share Price
ILA52.80
Change (1 day)
+0.00%
52-Week Range
ILA18.00 - ILA53.30
All Time High
ILA53.30
About

Erika Carmel-Tech Ltd develops, manufactures, markets, distributes, and sells the B-Cure laser products in Israel and internationally. It provides B-Cure Laser Classic, a non-invasive and safe medical device for the treatment of chronic and acute pain for home use; and B-Cure Laser Pro, a clinically proven, non-invasive and safe medical device for treatment of both acute and chronic conditions. T… Read more